arrow
T

Toshimitsu Hamasaki

George Washington University
H指数:51
被引数:8,949

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of 5-Aminolevulinic Acid Hydrochloride Combined with Sodium Ferrous Citrate in Pediatric Patients with Leigh Syndrome and Central Nervous System Disorders: An Initial Exploratory Trial with a Double-Blind Placebo-Controlled Period, Followed by an Open-Label Period and a Subsequent Long-Term Administration Study

5-氨基乙酰丙酸氯化物联合柠檬酸亚铁钠在患有 Leigh 综合征和中枢神经系统疾病的儿科患者中的疗效与安全性:一项具有双盲安慰剂对照期的初步探索性试验,随后进行开放标签期以及后续长期给药研究

2025-08-230
PRE
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies

诊断意向和诊断准确性研究中不同的研究重点

2025-03-270
PRE
Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs

使用六项抗菌药物注册试验探索医院获得性细菌性肺炎和呼吸机相关细菌性肺炎的潜在DOOR终点

2024-03-250
OA
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review
2023-10-162
PRE
Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group

引擎盖下: 抗菌药物耐药性领导小组的科学领导,临床操作,统计和数据管理以及实验室中心

2023-10-160
PRE
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group

抗菌药物耐药领导小组在革兰阴性菌感染研究中的重点与进展

2023-10-163
PRE
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
2023-09-225
OA
Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs
2023-04-196
OA
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
2023-04-0117
OAAI
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
2022-08-2922
OA
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection
2022-04-0912
OAAI
Influence of Induction Therapy Using Basiliximab With Delayed Tacrolimus Administration in Heart Transplant Recipients - Comparison With Standard Tacrolimus-Based Triple Immunosuppression -
2020-11-252
OA
A Novel Extracorporeal Continuous-Flow Ventricular Assist System for Patients With Advanced Heart Failure - Initial Clinical Experience -
2020-06-2510
OAAI